Track: Immuno-Oncology and Cancer Immunotherapy

Immuno-oncology and cancer immunotherapy have emerged as transformative approaches in modern cancer care, harnessing the body’s immune system to detect and eliminate malignancies. This session explores the complex mechanisms of tumor–immune interactions and the clinical application of immune-based therapies.

Immune Checkpoint Inhibitors & Novel Targets:

Explore recent advancements in immune checkpoint blockade, including PD-1/PD-L1 and CTLA-4 inhibitors, along with emerging immune targets. This sub-session focuses on optimizing patient selection, managing resistance, and improving clinical responses across cancer types.

CAR-T Cell Therapy & Adoptive Cell Transfer:

Delve into cutting-edge developments in CAR-T cell therapy, TCR-engineered cells, and other adoptive immune cell approaches. Discussions will focus on clinical successes, toxicity management, manufacturing challenges, and expansion of applications beyond hematologic malignancies.

Cancer Vaccines & Neoantigen-Based Therapies:

Examine innovations in therapeutic cancer vaccines and neoantigen-driven immunotherapies. This sub-session highlights strategies to stimulate tumor-specific immune responses and enhance long-term immune memory against cancer.

Tumor Microenvironment & Immune Modulation:

Uncover the complex interactions between tumors and the immune microenvironment. This sub-session addresses immune suppression mechanisms, stromal interactions, and therapeutic approaches aimed at reprogramming the tumor microenvironment to improve immunotherapy efficacy.

Biomarkers & Immune Profiling for Immunotherapy:

Discover the role of predictive biomarkers, immune signatures, and genomic profiling in guiding immunotherapy decisions. Topics include patient stratification, treatment monitoring, and minimizing immune-related adverse events through precision immuno-oncology.

Combination Immunotherapy Strategies:

Explore emerging combination approaches integrating immunotherapy with chemotherapy, radiotherapy, targeted therapy, and precision oncology. This sub-session highlights strategies to overcome resistance, enhance synergy, and improve survival outcomes in diverse cancer populations.

6th International Conference on Cancer Research and Treatment

Track: Immuno-Oncology and Cancer Immunotherapy

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at